Intrust Bank’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $225K | Sell |
4,292
-4,613
| -52% | -$244K | 0.02% | 395 |
|
|
2026
Q1 | $491K | Sell |
8,905
-3,738
| -30% | -$203K | 0.04% | 262 |
|
|
2025
Q4 | $620K | Buy |
12,643
+67
| +0.5% | +$3.13K | 0.05% | 223 |
|
|
2025
Q3 | $543K | Buy |
12,576
+1,574
| +14% | +$61.5K | 0.05% | 242 |
|
|
2025
Q2 | $422K | Buy |
+11,002
| New | +$420K | 0.04% | 282 |
|
|
2024
Q4 | – | Sell |
-6,257
| Closed | -$256K | – | 399 |
|
|
2024
Q3 | $256K | Sell |
6,257
-447
| -7% | -$18.3K | 0.03% | 348 |
|
|
2024
Q2 | $258K | Sell |
6,704
-214
| -3% | -$9K | 0.03% | 345 |
|
|
2024
Q1 | $297K | Sell |
6,918
-1,751
| -20% | -$72.2K | 0.03% | 334 |
|
|
2023
Q4 | $321K | Buy |
8,669
+1,099
| +15% | +$39.5K | 0.04% | 321 |
|
|
2023
Q3 | $274K | Sell |
7,570
-457
| -6% | -$16.2K | 0.04% | 317 |
|
|
2023
Q2 | $286K | Buy |
8,027
+1,561
| +24% | +$56K | 0.03% | 318 |
|
|
2023
Q1 | $230K | Buy |
6,466
+363
| +6% | +$12.7K | 0.03% | 354 |
|
|
2022
Q4 | $214K | Buy |
+6,103
| New | +$203K | 0.03% | 366 |
|
|
2020
Q4 | – | Sell |
-5,787
| Closed | -$272K | – | 368 |
|
|
2020
Q3 | $272K | Buy |
+5,787
| New | +$290K | 0.05% | 279 |
|
|
2020
Q1 | – | Sell |
-3,460
| Closed | -$203K | – | 327 |
|
|
2019
Q4 | $203K | Buy |
+3,460
| New | +$192K | 0.05% | 331 |
|
|
2018
Q4 | – | Sell |
-4,310
| Closed | -$216K | – | 376 |
|
|
2018
Q3 | $216K | Sell |
4,310
-60
| -1% | -$3.05K | 0.05% | 348 |
|
|
2018
Q2 | $220K | Buy |
+4,370
| New | +$220K | 0.06% | 344 |
|
|
2017
Q4 | – | Sell |
-4,277
| Closed | -$217K | – | 378 |
|
|
2017
Q3 | $217K | Buy |
4,277
+67
| +2% | +$3.4K | 0.07% | 345 |
|
|
2017
Q2 | $226K | Sell |
4,210
-236
| -5% | -$12.6K | 0.08% | 350 |
|
|
2017
Q1 | $234K | Buy |
4,446
+171
| +4% | +$8.68K | 0.08% | 334 |
|
|
2016
Q4 | $206K | Sell |
4,275
-2,910
| -41% | -$144K | 0.08% | 342 |
|
|
2016
Q3 | $388K | Sell |
7,185
-469
| -6% | -$25.7K | 0.15% | 215 |
|
|
2016
Q2 | $415K | Sell |
7,654
-199
| -3% | -$10.5K | 0.17% | 191 |
|
|
2016
Q1 | $398K | Sell |
7,853
-527
| -6% | -$26.2K | 0.14% | 188 |
|
|
2015
Q4 | $422K | Sell |
8,380
-926
| -10% | -$47.2K | 0.16% | 172 |
|
|
2015
Q3 | $447K | Buy |
9,306
+1,036
| +13% | +$53.9K | 0.17% | 160 |
|
|
2015
Q2 | $431K | Sell |
8,270
-28
| -0.3% | -$1.58K | 0.15% | 176 |
|
|
2015
Q1 | $479K | Sell |
8,298
-99
| -1% | -$5.68K | 0.17% | 154 |
|
|
2014
Q4 | $449K | Sell |
8,397
-777
| -8% | -$43.5K | 0.17% | 163 |
|
|
2014
Q3 | $527K | Buy |
9,174
+442
| +5% | +$27.1K | 0.2% | 144 |
|
|
2014
Q2 | $584K | Buy |
8,732
+334
| +4% | +$22.6K | 0.22% | 142 |
|
|
2014
Q1 | $561K | Sell |
8,398
-714
| -8% | -$48.3K | 0.23% | 137 |
|
|
2013
Q4 | $608K | Buy |
9,112
+213
| +2% | +$13.8K | 0.26% | 122 |
|
|
2013
Q3 | $558K | Sell |
8,899
-1,272
| -13% | -$81.9K | 0.27% | 122 |
|
|
2013
Q2 | $636K | Buy |
+10,171
| New | +$646K | 0.28% | 128 |
|
Other funds holding GSK
JEST
Intrust Bank's GSK Position: Q2 2026 in Review
Intrust Bank reduced its GSK (GSK) stake by 52% in Q2 2026, selling an estimated $244K and leaving 4,292 shares worth $225K. The position accounts for 0.02% of the portfolio, ranked #395.
Intrust Bank first reported a position in GSK in Q2 2013 and has held it in 35 quarters since. The position peaked at $636K in Q2 2013. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.
- Intrust Bank held 4,292 shares of GSK worth $225K as of Q2 2026.
- Intrust Bank sold 4,613 GSK shares in Q2 2026, an estimated $244K.
- GSK made up 0.02% of Intrust Bank's portfolio in Q2 2026, its #395 holding.
- Intrust Bank first reported a position in GSK in Q2 2013 and has held it in 35 quarters since.
- Intrust Bank's GSK position peaked at $636K in Q2 2013.
- 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.
Based on Intrust Bank's 13F filing for Q2 2026, filed 5 Aug 2026.